(Q43744070)

26 November 2017

title

1-Methyl-4-phenyl-pyridinium increases S-adenosyl-L-methionine dependent phospholipid methylation (English)

1 reference

26 November 2017

Lee ES

1

1 reference

26 November 2017

Charlton CG

series ordinal

2

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Pharmacology, Biochemistry and Behavior

26 November 2017

published in

1 reference

26 November 2017

volume

70

1 reference

26 November 2017

issue

1

1 reference

26 November 2017

page(s)

105-114

1 reference

1-Acyl-2-lysophosphatidylcholine transport across the blood-retina and blood-brain barrier

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Role of phospholipase A2 and membrane-derived lipid second messengers in membrane function and transcriptional activation of genes: implications in cerebral ischemia and neuronal excitability.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Mediators of injury in neurotrauma: intracellular signal transduction and gene expression

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

[Distribution of 5-hydroxytryptamine (serotonin) in the human brain and its behavior in patients with Parkinson's syndrome].

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Choline and cholinergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Intracerebroventricular administration of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and its metabolite 1-methyl-4-phenylpyridinium ion (MPP+) decrease dopamine and increase acetylcholine in the mouse neostriatum

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Substantia nigra degeneration and tyrosine hydroxylase depletion caused by excess S-adenosylmethionine in the rat brain. Support for an excess methylation hypothesis for parkinsonism.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Tremor induced by S-adenosyl-l-methionine: possible relation to L-dopa effects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Potential parkinsonian protoxicants within and without

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Indole-N-methylated β-carbolinium ions as potential brain-bioactivated neurotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Identification and properties of methyltransferases that synthesize phosphatidylcholine in rat brain synaptosomes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

S-adenosyl-L-methionine decreases motor activity in the rat: similarity to Parkinson's disease-like symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Apoptosis and DNA degradation induced by 1-methyl-4-phenylpyridinium in neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

MPTP- and MPP(+)-induced effects on body temperature exhibit age- and strain-dependence in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Identification of dopamine, noradrenaline and 5-hydroxytryptamine varicosities in a fraction containing nerve ending particles

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Acute MPTP treatment produces no changes in mitochondrial complex activities and indices of oxidative damage in the common marmoset ex vivo one week after exposure to the toxin

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Reactive oxygen species and the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Enzymatic methylation of phosphatidylethanolamine increases erythrocyte membrane fluidity

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Phospholipid Methylation and Biological Signal Transmission

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Identification and properties of two methyltransferases in conversion of phosphatidylethanolamine to phosphatidylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Lecithin consumption increases acetylcholine concentrations in rat brain and adrenal gland

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

The mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity: role of intracellular calcium

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicity in non-human primates is antagonized by pretreatment with nimodipine at the nigral, but not at the striatal level.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Selective nigral toxicity after systemic administration of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyrine (MPTP) in the squirrel monkey

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Inhibition of complex I by isoquinoline derivatives structurally related to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine(MPTP)

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Role of N-methyl-D-aspartate (NMDA) receptors in experimental catalepsy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and 1-methyl-4-phenylpyridinium ion on activities of the enzymes in the electron transport system in mouse brain

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Apoptosis is induced by 1-methyl-4-phenylpyridinium ion (MPP+) in ventral mesencephalic-striatal co-culture in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Progesterone-induced phospholipid N-methylation and sphingomyelin synthesis in the amphibian oocyte plasma membrane: a second source of the 1,2-diacylglycerol second messenger associated with the G2/M transition.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Isoquinoline neurotoxins in the brain and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

An endogenous substance of the brain, tetrahydroisoquinoline, produces parkinsonism in primates with decreased dopamine, tyrosine hydroxylase and biopterin in the nigrostriatal regions

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Inhibition of NADH-linked oxidation in brain mitochondria by 1-methyl-4-phenyl-pyridine, a metabolite of the neurotoxin, 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

In vivo intracerebral microdialysis studies in rats of MPP+ analogues and related charged species.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Neurochemical and behavioural features induced by chronic low dose treatment with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset: implications for Parkinson's disease?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Effect of long-term administration of 1,2,3,4-tetrahydroisoquinoline (TIQ) on striatal dopamine and 3,4-dihydroxyphenylacetic acid (DOPAC) content in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Reduction of cortical dopamine, noradrenaline, serotonin and their metabolites in Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Concentrations of serotonin and its related substances in the cerebrospinal fluid of parkinsonian patients and their relations to the severity of symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Characterization of phospholipid methylation in rat brain myelin.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Protein kinase C catalyses the phosphorylation and activation of rat liver phospholipid methyltransferase

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

Parkinsonism in monkeys produced by chronic administration of an endogenous substance of the brain, tetrahydroisoquinoline: the behavioral and biochemical changes

1 reference

https://api.crossref.org/works/10.1016%2FS0091-3057%2801%2900588-3

7 January 2021

10.1016/S0091-3057(01)00588-3

Identifiers

DOI

1 reference

26 November 2017

1 reference